BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Clin Oncol. Nov 24, 2026; 17(11): 122944
Published online Nov 24, 2026. doi: 10.5306/wjco.122944
Table 1 Baseline characteristics of the patients in the four cohorts, n (%)
Characteristics
Group I (n = 1029)
Group II (n = 157)
Group III (n = 154)
Group IV (n = 210)
P value
Age > 60 years323 (31.4)65 (41.4)46 (29.9)90 (42.9)0.001
Male897 (87.2)145 (92.4)116 (75.3)167 (79.5)< 0.001
BMI > 24 kg/m2513 (49.9)74 (47.1)60 (39.0)82 (39.0)0.005
Hypertension251 (24.4)38 (24.2)25 (16.2)44 (21.0)0.127
Diabetes126 (12.2)23 (14.6)26 (16.9)32 (15.2)0.305
Alcohol consumption318 (30.9)54 (34.4)33 (21.4)62 (29.5)0.065
ASA score >2 135 (13.1)25 (15.9)24 (15.6)32 (15.2)0.629
HBV (+)827 (80.4)122 (77.7)136 (88.3)184 (87.6)0.006
Cirrhosis610 (59.3)103 (65.6)109 (70.8)169 (80.5)< 0.001
Portal hypertension137 (13.3)24 (15.3)32 (20.8)81 (38.6)< 0.001
Child-Pugh grade A1029 (100.0)157 (100.0)150 (97.4)201 (95.7)< 0.001
Total bilirubin > 17.1 μmol/L293 (28.5)27 (17.2)56 (36.4)54 (25.7)0.002
Preoperative ALT level > 40 U/L221 (21.5)47 (29.9)43 (27.9)89 (42.4)< 0.001
Preoperative AST level > 40 U/L155 (15.1)35 (22.3)51 (33.1)107 (51.0)< 0.001
Preoperative AFP level > 400 μg/L256 (24.9)41 (26.1)63 (40.9)69 (32.9)< 0.001
Largest tumor diameter > 5 cm398 (38.7)76 (48.4)92 (59.7)127 (60.5)< 0.001
Multiple tumors122 (11.9)20 (12.7)26 (16.9)34 (16.2)0.162
Microvascular invasion394 (38.3)77 (49.0)78 (50.6)103 (49.0)< 0.001
Macrovascular invasion34 (3.3)5 (3.2)15 (9.7)18 (8.6)< 0.001
Satellites86 (8.4)14 (8.9)24 (15.6)32 (15.2)0.002
Poor tumor differentiation486 (47.2)86 (54.8)89 (57.8)126 (60.0)0.001
Incomplete tumor encapsulation739 (71.8)126 (80.3)137 (89.0)171 (81.4)< 0.001
BCLC stage< 0.001
BCLC A stage863 (83.9)117 (74.5)107 (69.5)139 (66.2)
BCLC B stage68 (6.6)14 (8.9)14 (9.1)18 (8.6)
BCLC C stage98 (9.5)26 (16.6)33 (21.4)53 (25.2)
Operative variables
Operation time120 (100-155)135 (102-166)145 (110-175)140 (105-175)< 0.001
Intraoperative blood loss > 400 mL94 (9.1)24 (15.3)30 (19.5)45 (21.4)< 0.001
Intraoperative blood transfusion 27 (2.6)6 (3.8)10 (6.5)22 (10.5)< 0.001
Major liver resection132 (12.8)29 (18.5)39 (25.3)53 (25.2)< 0.001
Non-anatomical liver resection892 (86.7)131 (83.4)133 (86.4)178 (84.8)0.673
Resection margin < 1 cm673 (65.4)117 (74.5)110 (71.4)164 (78.1)0.001
Table 2 Long-term outcomes after excluding postoperative early deaths, n (%)/mean ± SD

Group I (n = 1029)
Group II (n = 157)
Group III (n = 154)
Group IV (n = 210)
P value
Period of follow-up (months)57.3 ± 21.953.9 ± 25.446.0 ± 24.341.7 ± 22.7< 0.001
Recurrence during the follow-up541 (52.6)97 (61.8)106 (68.8)148 (70.5)< 0.001
Intrahepatic recurrence499 (48.5)89 (56.7)90 (58.4)130 (61.9)0.001
Extrahepatic recurrence18 (1.7)3 (1.9)4 (2.6)5 (2.4)0.858
Intra- and extrahepatic recurrence24 (2.3)5 (3.2)12 (7.8)13 (6.5)0.001
BCLC stage of initial recurrence541 (52.6)97 (61.8)106 (68.8)148 (70.5)< 0.001
BCLC A stage345 (33.5)55 (35.0)53 (34.4)61 (29.0)0.568
BCLC B stage142 (13.8)31 (19.7)31 (20.1)61 (29.0)< 0.001
BCLC C stage54 (5.2)11 (7.0)22 (14.3)26 (12.4)< 0.001
Mortality during the follow-up380 (36.9)74 (47.1)85 (55.2)136 (64.8)< 0.001
Cancer-specific mortality318 (30.9)65 (41.4)73 (47.4)117 (55.7)< 0.001
Non-cancer-specific mortality62 (6.0)9 (5.7)12 (7.8)19 (9.0)0.370
Overall survival 107.7 (-)76.4 (57.8-95.0)51.0 (33.6-68.5)43.0 (33.8-52.2)< 0.001
1-year OS rate (%)96.191.791.688.1
3-year OS rate (%)80.373.263.071.0
5-year OS rate (%)68.259.447.836.7
Recurrence free survival 48.8 (41.7-55.9)38.4 (21.9-55.0)19.2 (12.2-26.2)13.6 (8.9-18.3)< 0.001
1-year RFS rate (%)75.972.059.753.3
3-year RFS rate (%)56.050.335.732.9
5-year RFS rate (%)45.639.129.724.2
Table 3 Univariable Cox regression analyses for overall survival and recurrence-free survival
VariablesHR comparisonOS
RFS
HR (95%CI)
UV P value
HR (95%CI)
UV P value
Study centerHe’nan vs Xi’an vs Shang’hai1.01 (0.92-1.12)0.8150.99 (0.91-1.07)0.781
Age> 60 years vs ≤ 60 years1.01 (0.94-1.29)0.1931.07 (0.94-1.22)0.315
SexMale vs female1.02 (0.81-1.24)0.9851.17 (0.98-1.41)0.090
HypertensionYes vs no1.00 (0.81-1.24)0.9231.10 (0.95-1.27)0.196
Diabetes mellitusYes vs no1.02 (0.82-1.27)0.8851.07 (0.90-1.29)0.448
Alcohol consumptionYes vs no1.09 (0.93-1.28)0.2931.10 (0.97-1.27)0.131
ASA score> 2 vs ≤ 21.07 (0.87-1.32)0.5320.96 (0.81-1.15)0.687
HBV (+)Positive vs negative1.15 (0.94-1.41)0.1991.21 (1.02-1.43)0.027
CirrhosisPresence vs absence1.40 (1.19-1.65)< 0.0011.53 (1.33-1.75)< 0.001
Portal hypertensionPresence vs absence1.15 (0.95-1.39)0.1601.18 (1.01-1.38)0.041
Bilirubin> 17.1 μmol/L vs ≤ 17.1 μmol/L1.18 (0.95-1.32)0.1921.17 (1.02-1.34)0.026
Preoperative ALT level> 40 U/L vs ≤ 40 U/L1.50 (1.28-1.77)< 0.0011.51 (1.31-1.73)< 0.001
Preoperative AST level> 40 U/L vs ≤ 40 U/L1.94 (1.64-2.28)< 0.0011.75 (1.52-2.02)< 0.001
Preoperative AFP level> 400 μg/L vs ≤ 400 μg/L1.87 (1.60-2.19)< 0.0011.54 (1.34-1.74)< 0.001
Largest tumor diameter> 5 cm vs ≤ 5 cm2.60 (2.23-3.04)< 0.0012.00 (1.77-2.27)< 0.001
Tumor numberMultiple vs solitary1.96 (1.62-2.39)< 0.0012.13 (1.80-2.52)< 0.001
Microvascular invasionYes vs no2.17 (1.86-2.53)< 0.0011.74 (1.53-1.97)< 0.001
Macrovascular invasionYes vs no6.09 (4.69-7.90)< 0.0015.04 (3.92-6.47)< 0.001
SatellitesYes vs no2.85 (2.33-3.49)< 0.0013.03 (2.53-3.63)< 0.001
Poor tumor differentiationYes vs no1.13 (0.97-1.32)0.1061.06 (0.93-1.20)0.370
Incomplete tumor encapsulationYes vs no1.70 (1.40-2.06)< 0.0011.38 (1.18-1.61)< 0.001
Intraoperative blood loss> 400 mL vs ≤ 400 mL2.29 (1.88-2.77)< 0.0012.08 (1.75-2.47)< 0.001
Intraoperative transfusionYes vs no2.88 (2.16-3.84)< 0.0012.55 (1.95-3.34)< 0.001
Extent of liver resectionMajor vs ≤ minor 1.97 (1.64-2.36)< 0.0011.78 (1.52-2.09)< 0.001
Non-anatomical liver resectionYes vs no0.79 (0.65-0.98)0.0290.91 (0.76-1.09)0.310
Resection margin< 1 cm vs ≥ 1 cm1.86 (1.55-2.23)< 0.0011.61 (1.39-1.86)< 0.001
Preoperative albumin level< 40 g/L vs ≥ 40 g/L1.75 (1.49-2.06)< 0.0011.50 (1.30-1.73)< 0.001
Preoperative prealbumin level< 170 mg/L vs ≥ 170 mg/L2.10 (1.79-2.47)< 0.0011.76 (1.53-2.02)< 0.001
Albumin and prealbumin statusGroup I vs1.001.00
Group II1.37 (1.07-1.76)0.0131.25 (1.02-1.54)0.033
Group III1.89 (1.49-2.39)< 0.0011.65 (1.34-2.02)< 0.001
Group IV2.46 (2.02-2.99)< 0.0011.95 (1.64-2.32)< 0.001
Table 4 Multivariable Cox regression analyses for overall survival in different models
VariablesHR comparisonModel 11
Model 22
Model 33
Model 44
HR (95%CI)
MV P value
HR (95%CI)
MV P value
HR (95%CI)
MV P value
HR (95%CI)
MV P value
Age> 60 years vs ≤ 60 years--------
SexMale vs female--------
HypertensionYes vs no--------
Diabetes mellitusYes vs no--------
Alcohol consumptionYes vs no--------
ASA score> 2 vs ≤ 2--------
HBV (+)Positive vs negative--------
CirrhosisPresence vs absence1.35 (1.13-1.60)0.0011.33 (1.12-1.57)0.0011.33 (1.12-1.57)0.0011.33 (1.12-1.57)0.001
Portal hypertensionPresence vs absence--------
Bilirubin> 17.1 μmol/L vs ≤ 17.1 μmol/L--------
Preoperative ALT level> 40 U/L vs ≤ 40 U/L1.19 (1.01-1.41)0.0371.19 (1.01-1.40)0.0431.19 (1.01-1.40)0.043NS0.059
Preoperative AST level> 40 U/L vs ≤ 40 U/LNS0.934NS0.551NS0.551NS0.743
Preoperative AFP level> 400 μg/L vs ≤ 400 μg/L1.25 (1.05-1.48)0.0121.21 (1.02-1.44)0.0291.21 (1.02-1.44)0.0291.21 (1.02-1.44)0.029
Largest tumor diameter> 5 cm vs ≤ 5 cm2.11 (1.79-2.49)< 0.0012.07 (1.75-2.45)< 0.0012.07 (1.75-2.45)< 0.0012.08 (1.76-2.46)< 0.001
Tumor numberMultiple vs solitary1.56 (1.27-1.91)< 0.0011.55 (1.27-1.90)< 0.0011.55 (1.27-1.90)< 0.0011.57 (1.28-1.92)< 0.001
Microvascular invasionYes vs no1.60 (1.36-1.88)< 0.0011.63 (1.39-1.92)< 0.0011.63 (1.39-1.92)< 0.0011.62 (1.37-1.90)< 0.001
Macrovascular invasionYes vs no2.69 (2.03-3.56)< 0.0012.62 (1.97-3.47)< 0.0012.62 (1.97-3.47)< 0.0012.62 (1.97-3.48)< 0.001
SatellitesYes vs no1.64 (1.32-2.03)< 0.0011.59 (1.28-1.97)< 0.0011.59 (1.28-1.97)< 0.0011.63 (1.31-2.02)< 0.001
Poor tumor differentiationYes vs no--------
Incomplete tumor encapsulationYes vs no1.51 (1.24-1.85)< 0.0011.48 (1.22-1.81)< 0.0011.48 (1.22-1.81)< 0.0011.47 (1.20-1.79)< 0.001
Intraoperative blood loss> 400 vs ≤ 400 mLNS0.077NS0.095NS0.095NS0.073
Intraoperative transfusionYes vs noNS0.177NS0.235NS0.235NS0.226
Extent of liver resectionMajor vs ≤ minor NS0.578NS0.700NS0.700NS0.687
Non-anatomical liver resectionYes vs noNS0.386NS0.499NS0.499NS0.450
Resection margin< 1 cm vs ≥ 1 cm1.47 (1.22-1.78)< 0.0011.48 (1.23-1.78)< 0.0011.48 (1.23-1.78)< 0.0011.49 (1.24-1.79)< 0.001
Preoperative albumin level< 40 g/L vs ≥ 40 g/L1.35 (1.14-1.59)0.001--NS0.082--
Preoperative prealbumin level< 170 mg/L vs ≥ 170 mg/L--1.47 (1.24-1.74)< 0.0011.47 (1.24-1.74)< 0.001--
Albumin and prealbumin statusGroup I vs------1.00
Group II------1.22 (0.95-1.57)0.122
Group III------1.41 (1.11-1.79)0.005
Group IV------1.65 (1.34-2.02)< 0.001
Table 5 Multivariable Cox regression analyses for recurrence-free survival in different models
VariablesHR comparisonModel 11
Model 22
Model 33
Model 44
HR (95%CI)
MV P value
HR (95%CI)
MV P value
HR (95%CI)
MV P value
HR (95%CI)
MV P value
Age> 60 years vs ≤ 60 years--------
SexMale vs femaleNS0.256NS0.104NS0.104NS0.116
HypertensionYes vs no--------
Diabetes mellitusYes vs no--------
Alcohol consumptionYes vs no--------
ASA score> 2 vs ≤ 2--------
HBV (+)Positive vs negativeNS0.922NS0.797NS0.797NS0.838
CirrhosisPresence vs absence1.44 (1.25-1.66)< 0.0011.41 (1.22-1.63)< 0.0011.41 (1.22-1.63)< 0.0011.41 (1.22-1.63)< 0.001
Portal hypertensionPresence vs absenceNS0.315NS0.207NS0.207NS0.180
Bilirubin> 17.1 μmol/L vs ≤ 17.1 μmol/L1.21 (1.05-1.39)0.0071.19 (1.04-1.37)0.0131.19 (1.04-1.37)0.0131.20 (1.04-1.38)0.011
Preoperative ALT level> 40 U/L vs ≤ 40 U/L1.25 (1.09-1.44)0.0021.24 (1.08-1.43)0.0031.24 (1.08-1.43)0.0031.24 (1.07-1.43)0.003
Preoperative AST level> 40 U/L vs ≤ 40 U/LNS0.975NS0.712NS0.712NS0.699
Preoperative AFP level> 400 μg/L vs ≤ 400 μg/LNS0.069NS0.106NS0.106NS0.102
Largest tumor diameter> 5 cm vs ≤ 5 cm1.73 (1.51-1.98)< 0.0011.70 (1.48-1.95)< 0.0011.70 (1.48-1.95)< 0.0011.69 (1.48-1.94)< 0.001
Tumor numberMultiple vs solitary1.80 (1.51-2.14)< 0.0011.81 (1.52-2.15)< 0.0011.81 (1.52-2.15)< 0.0011.81 (1.52-2.16)< 0.001
Microvascular invasionYes vs no1.39 (1.22-1.59)< 0.0011.41 (1.24-1.61)< 0.0011.41 (1.24-1.61)< 0.0011.41 (1.24-1.61)< 0.001
Macrovascular invasionYes vs no2.89 (2.22-3.75)< 0.0012.83 (2.18-3.68)< 0.0012.83 (2.18-3.68)< 0.0012.85 (2.19-3.71)< 0.001
SatellitesYes vs no1.96 (1.62-2.37)< 0.0011.95 (1.61-2.35)< 0.0011.95 (1.61-2.35)< 0.0011.95 (1.61-2.36)< 0.001
Poor tumor differentiationYes vs no--------
Incomplete tumor encapsulationYes vs no1.33 (1.14-1.56)< 0.0011.30 (1.11-1.52)0.0011.30 (1.11-1.52)0.0011.30 (1.11-1.52)0.001
Intraoperative blood loss> 400 mL vs ≤ 400 mL1.32 (1.10-1.57)0.0031.30 (1.09-1.56)0.0041.30 (1.09-1.56)0.0041.30 (1.08-1.55)0.005
Intraoperative transfusionYes vs noNS0.245NS0.316NS0.316NS0.290
Extent of liver resectionMajor vs ≤ minor NS0.143NS0.198NS0.198NS0.200
Non-anatomical liver resectionYes vs no--------
Resection margin< 1 cm vs ≥ 1 cm1.29 (1.11-1.49)0.0011.28 (1.11-1.49)0.0011.28 (1.11-1.49)0.0011.28 (1.10-1.48)0.001
Preoperative albumin level< 40 g/L vs ≥ 40 g/L1.19 (1.02-1.36)0.027--NS0.411--
Preoperative prealbumin level< 170 mg/L vs ≥ 170 mg/L--1.30 (1.12-1.50)0.0011.30 (1.12-1.50)0.001--
Albumin and prealbumin statusGroup I vs------1.00
Group II------1.10 (0.89-1.36)0.359
Group III------1.30 (1.06-1.60)0.014
Group IV------1.33 (1.10-1.60)0.002


Write to the Help Desk